Preview

Experimental and Clinical Gastroenterology

Advanced search

Non-variceal gastrointestinal bleeding in patients with cardiovascular diseases

https://doi.org/10.31146/1682-8658-ecg-228-8-28-36

Abstract

Objective: To study the condition of the upper gastrointestinal mucosa, frequency of gastrointestinal bleeding, risk factors according to the “REGATA” scale (2021), and assess the effectiveness of endoscopic hemostasis methods in patients with atherosclerosis. Materials and Methods: We studied 118 patients (main group - MG) with atherosclerosis of the visceral branches of the abdominal aorta and 120 patients (control group - CG) without atherosclerosis of these branches but with coronary artery atherosclerosis. Diagnosis of erosive changes in the upper GI tract and verification of the source of gastrointestinal bleeding were confirmed by endoscopic examination. The severity of ulcer bleeding was assessed using a modified Forrest classification. The “REGATA” scale was used to assess the risk of gastrointestinal bleeding. Results: The MG patients showed a high frequency of gastric erosions (75.4%) against a background of diffuse (48.3%) or focal (45.9%) atrophy of the gastric mucosa. Gastric ulcers were diagnosed in 27.1% and duodenal ulcers in 12.7% of OG patients. The high risk of gastrointestinal bleeding according to the “REGATA” scale was observed in 77.1% of MG patients, which was significantly higher than in CG (64.2%) (p<0.05). Ulcer bleeding was identified in 16.1% of MG patients and 4.2% of CG patients. Combined endoscopic hemostasis was performed in all cases of gastrointestinal bleeding. Recurrent bleeding occurred in two cases. Conclusion: Patients with coronary artery disease and atherosclerosis of visceral branches of the abdominal aorta who receive long-term antiplatelet therapy are at high risk of gastrointestinal bleeding. Esophagogastroduodenoscopy (EGD) is the main method for diagnosing erosive-ulcerative lesions and identifying the source of bleeding. Endoscopic hemostasis effectively stops bleeding in the majority of cases.

About the Authors

A. G. Shuleshova
Central State Medical Academy of the Administration of the President of the Russian Federation
Russian Federation


A. A. Lisitsa
Central State Medical Academy of the Administration of the President of the Russian Federation
Russian Federation


D. V. Danilov
Central State Medical Academy of the Administration of the President of the Russian Federation
Russian Federation


I. G. Repin
Central State Medical Academy of the Administration of the President of the Russian Federation
Russian Federation


References

1. Kochetkov A.I., Ostroumova O. D., Pereverzev A. P. et al. Experts consensus on reducing the risk of gastrointestinal bleeding in patients receiving oral anticoagulants. Therapy. 2021;(10):23-41. (in Russ.) doi: 10.18565/therapy.2021.10.23-41.@@ Кочетков А. И., Остроумова О. Д., Переверзев А. П. и др. Консенсус экспертов по снижению риска желудочно-кишечных кровотечений у пациентов, получающих оральные антикоагулянты. Терапия. 2021;(10):23-41. doi: 10.18565/therapy.2021.10.23-41

2. Selyanina A. A., Dolgushina A. I., Kusnezowa A. S., Genkel V. V., Olevskaya E. R., Nikushkina K. V., Khikhlova A. O. Features of the upper gastrointestinal tract mucous membrane state in patients with atherosclerosis of the mesenteric arteries. Terapevticheskii arkhiv. 2023;95(2):152-157. (in Russ.) doi: 10.26442/00403660.2023.02.202058.@@ Селянина А. А., Долгушина А. И., Кузнецова А. С., Генкель В. В., Олевская Е. Р., Никушкина К. В., Хихлова А. О. Особенности состояния слизистой оболочки верхних отделов желудочно-кишечного тракта у пациентов с атеросклерозом мезентериальных артерий. Терапевтический архив. 2023;95(2):152-157. doi: 10.26442/00403660.2023.02.202058.

3. Komarov A. L., Shakhmatova O. O., Korobkova V. V. et al. Risk factors and outcomes of gastrointestinal bleeding in patients with stable coronary artery disease: data from the observational registry of long-term antithrombotic therapy REGATTA-1.Russian Journal of Cardiology. 2021;26(6):4465. doi: 10.15829/1560-4071-2021-4465.@@ Комаров А. Л., Шахматова О. О., Коробкова В. В. и др. Факторы риска и исходы желудочно-кишечных кровотечений у больных стабильной ишемической болезнью сердца: данные наблюдательного регистра длительной антитромботической терапии РЕГАТА-1. Российский кардиологический журнал. 2021;26(6):4465. doi:10.15829/1560-4071-2021-4465.

4. Costa F., van Klaveren D., James S., Heg D., Räber L., Feres F., Pilgrim T., Hong M. K., Kim H. S., Colombo A., Steg P. G., Zanchin T., Palmerini T., Wallentin L., Bhatt D. L., Stone G. W., Windecker S., Steyerberg E. W., Valgimigli M.; PRECISE-DAPT Study Investigators. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet. 2017 Mar 11;389(10073):1025-1034. doi: 10.1016/S0140-6736(17)30397-5.

5. Urban P., Mehran R., Colleran R. et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. Eur Heart J. 2019 Aug 14;40(31):2632-2653. doi: 10.1093/eurheartj/ehz372.

6. Roffi M., Patrono C., Collet J. P., Mueller C., Valgimigli M., Andreotti F., Bax J. J., Borger M. A., Brotons C., Chew D. P., Gencer B., Hasenfuss G., Kjeldsen K., Lancellotti P., Landmesser U., Mehilli J., Mukherjee D., Storey R. F., Windecker S.; ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016 Jan 14;37(3):267-315. doi: 10.1093/eurheartj/ehv320.

7. Hindricks G., Potpara T., Dagres N. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).Russian Journal of Cardiology. 2021;26(9):4701. (In Russ.) doi: 10.15829/1560-4071-2021-4701.@@ Hindricks G., Potpara T., Dagres N. и др. Рекомендации ESC 2020 по диагностике и лечению пациентов с фибрилляцией предсердий, разработанные совместно с европейской ассоциацией кардиоторакальной хирургии (EACTS). Российский кардиологический журнал. 2021;26(9):4701. doi: 10.15829/1560-4071-2021-4701.

8. Ostroumova O. D., Volkova E. A., Kochetkov A. I., Pereverzev A. P., Tkacheva O. N. Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors. Cardiovascular Therapy and Prevention. 2019;18(5):128-137. (In Russ.) doi: 10.15829/1728-8800-2019-5-128-137.@@ Остроумова О. Д., Волкова Е. А., Кочетков А. И., Переверзев А. П., Ткачёва О. Н. Профилактика желудочно-кишечных кровотечений у пациентов, получающих пероральные антикоагулянты: фокус на ингибиторы протонной помпы. Кардиоваскулярная терапия и профилактика. 2019;18(5):128-137. doi: 10.15829/1728-8800-2019-5-128-137.

9. Oinotkinova O. Sh. The diagnostic criteria for chronic abdominal ischemia and the methods for its correction.Russian Journal of Evidence-Based Gastroenterology. 2017;6(1):9-20. (In Russ.) doi: 10.17116/dokgastro2017619-20.@@ Ойноткинова О. Ш. Диагностические критерии абдоминальной ишемической болезни и методы коррекции. Доказательная гастроэнтерология. 2017;6(1):9-20. doi: 10.17116/dokgastro2017619-20

10. Kenngott S., Olze R., Kollmer M., Bottheim H., Laner A., Holinski-Feder E., Gross M. Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution? Eur J Med Res. 2010 May 18;15(5):220-4. doi: 10.1186/2047-783x-15-5-220.


Review

For citations:


Shuleshova A.G., Lisitsa A.A., Danilov D.V., Repin I.G. Non-variceal gastrointestinal bleeding in patients with cardiovascular diseases. Experimental and Clinical Gastroenterology. 2024;(8):28-36. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-228-8-28-36

Views: 577


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)